Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 42: | Line 42: | ||
****[[Hepatocyte Growth Factor Receptor]] | ****[[Hepatocyte Growth Factor Receptor]] | ||
****[[Human Epidermal Growth Factor Receptor 2]] | ****[[Human Epidermal Growth Factor Receptor 2]] | ||
| + | ***[[Farnesoid X Receptor]] | ||
| + | ***[[Molecular_Playground/FIH|Hypoxia Inducible Factor (HIF)]] | ||
| + | ***[[Heat Shock Protein 90]] | ||
****Insulin-Like Growth Factor | ****Insulin-Like Growth Factor | ||
*****[[Insulin-Like Growth Factor-1]] | *****[[Insulin-Like Growth Factor-1]] | ||
| Line 58: | Line 61: | ||
****[[Phosphatidylinositol 3-Kinase]] | ****[[Phosphatidylinositol 3-Kinase]] | ||
****[[SRC]] | ****[[SRC]] | ||
| - | ***[[Farnesoid X Receptor]] | ||
| - | ***[[Molecular_Playground/FIH|Hypoxia Inducible Factor (HIF)]] | ||
| - | ***[[Heat Shock Protein 90]] | ||
***[[p53]] | ***[[p53]] | ||
***[[Molecular_Playground/Taxol|Taxol Information]] | ***[[Molecular_Playground/Taxol|Taxol Information]] | ||
Revision as of 10:46, 24 September 2010
The following is a list of major pharmaceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
